Search - tctmd.com

Displaying 61 - 80 of 294

Sort: Relevancy | Date

Presentation CHIP Florida 2017

Is PCI Overused?

Presenter: Ajay J. Kirtane

January 21, 2017

Presentation Cardiovascular Interventions 2016

Unprotected Left Main Stenting

Presenter: Paul S. Teirstein

November 10, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

Presenter: Howard C. Herrmann, Robert J. de Winter, David E. Thaler

November 01, 2016

Presentation

Timing, Risk Factors, Outcomes of Stroke, TIA after TAVR: PARTNER Trial

Presenter: Samir Kapadia

September 12, 2016

Presentation

Neurological Events Following TAVR and Their Predictors: CoreValve Trials

Presenter: Neal Kleiman

September 12, 2016

Presentation ESC 2016

Feasibility and Safety of Direct Catheter - Based Thrombectomy in the Treatment of Acute Ischemic Stroke: Prospective Registry PRAGUE-16

Presenter: Petr Widimsky

August 27, 2016

Presentation TVT 2016

What Do I Do With a Patient With Cryptogenic Stroke?

Presenter: Creighton W. Don

June 18, 2016

Presentation TVT 2016

Strokes After TAVR: Etiologies, Declining Frequency, and Current and Future Therapies

Presenter: Samir R. Kapadia

June 17, 2016

Presentation TVT 2016

TVT 1039: Transcatheter Aortic Valve Replacement With Evolut-R CoreValve to Simultaneously Treat Severe Calcific Aortic Stenosis and a Large Aortic Root Pseudo-aneurysm in a High-risk Patient

Presenter: Nirat Beohar

June 17, 2016

Presentation CCVVC 2016

Telemedicine in Interventional Cardiology

Presenter: Roberto Botelho

June 16, 2016

Presentation SOLACI 2016

Future Directions in TAVR: From Moderate-Low Risk Patients to New Devices

Presenter: Martin B. Leon

June 10, 2016

Presentation EuroPCR 2016

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

Presenter: Jens Erik Nielsen-Kudsk

May 20, 2016

Presentation EuroPCR 2016

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

Presenter: Alexandra Lansky

May 20, 2016

Presentation

Trends in Acute Ischemic Stroke Hospitalizations in the United States

Presenter: Lucas Ramirez

May 11, 2016

Presentation

Meta-analysis of the Long-Term Effect of Routine Aspiration Thrombectomy in Primary PCI Patients

Presenter: JG. Mancini

May 02, 2016

Presentation

Usefulness of Predilatation Prior to Transcatheter Aortic Valve Replacement

Presenter: Matteo Pagnesi

April 29, 2016

Presentation ECHO 2016

Clinical Decision Making: Stroke and Structural Interventions

Presenter: Robert J. Sommer

March 23, 2016

Presentation ECHO 2016

Hemodynamics I Building Blocks of Quantitation

Presenter: Neil J. Weissman

March 21, 2016

Presentation JIM 2016

The Italian Experience with the Amplatzer Technology

Presenter: Jacopo A Oreglia

February 10, 2016

Advertisement

Is PCI Overused?

Unprotected Left Main Stenting

Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

Timing, Risk Factors, Outcomes of Stroke, TIA after TAVR: PARTNER Trial

Neurological Events Following TAVR and Their Predictors: CoreValve Trials

Feasibility and Safety of Direct Catheter - Based Thrombectomy in the Treatment of Acute Ischemic Stroke: Prospective Registry PRAGUE-16

What Do I Do With a Patient With Cryptogenic Stroke?

Strokes After TAVR: Etiologies, Declining Frequency, and Current and Future Therapies

TVT 1039: Transcatheter Aortic Valve Replacement With Evolut-R CoreValve to Simultaneously Treat Severe Calcific Aortic Stenosis and a Large Aortic Root Pseudo-aneurysm in a High-risk Patient

Telemedicine in Interventional Cardiology

Future Directions in TAVR: From Moderate-Low Risk Patients to New Devices

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

Trends in Acute Ischemic Stroke Hospitalizations in the United States

Meta-analysis of the Long-Term Effect of Routine Aspiration Thrombectomy in Primary PCI Patients

Usefulness of Predilatation Prior to Transcatheter Aortic Valve Replacement

Clinical Decision Making: Stroke and Structural Interventions

Hemodynamics I Building Blocks of Quantitation

The Italian Experience with the Amplatzer Technology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content